This review summarizes the emerging pharmacological approaches for treating ascites in different stages of cirrhosis, encompassing antiplatelet agents, anticoagulants, NSBBs, long-term albumin infusion, and SGLT2i, and highlights the knowledge gaps. This evidence concerns the gene ALB and Cirrhosis.